Skip to main content
. 2021 Jan 8;26(1):1–9. doi: 10.1080/13510002.2021.1871814

Figure 4.

Figure 4.

BPH condition amended by reducing cell proliferation: Human BPH-1 cells were treated with NF 3, 9 µM and SFN 15 µM for 48 h. A. After treated for 48 h, alive cells were determined with immunofluorescence analysis using DAPI staining, B. Relative Fluorescence intensity. Values are presented as means ± SD (n = 3). For NF: ***P< 0.001 compared to control group. For SFN: ##P< 0.01 compared to control group (no treatment).